Norway· NO-ID_738AE9FD-BCAE-4DBD-85EB-B21DF1B55C54
Vyepti
A eptinezumab product containing eptinezumab, registered in Norway by H. Lundbeck A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Eptinezumab is registered in 14 of 19 countries.
Countries holding a registration under ATC N02CD05 (eptinezumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Eptinezumab · ATC N02CD05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Eptinezumab
- Manufacturer
- H. Lundbeck A/S
- Country
- Norway (NO)
- ATC code
- N02CD05
- ATC class
- Eptinezumab
- Defined daily dose
- 1.1 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- gtin5702150154828
- no_varenummer085136100NOK 16283.8
- no_merkevare_idID_738AE9FD-BCAE-4DBD-85EB-B21DF1B55C54
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eptinezumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVYEPTIAbacus Medicine A/S
- CzechiaVYEPTIH. Lundbeck A/S, Valby
- BelgiumVyepti 100 mgH. Lundbeck
- IrelandVYEPTI 100 mg concentrate for solution for infusionH. Lundbeck A/S
- IcelandVyeptiH. Lundbeck A/S*
- SwedenVyepti 100 mg Koncentrat till infusionsvätska, lösningH. Lundbeck A/S
- United StatesVyeptiLundbeck Pharmaceuticals LLC
- SpainVYEPTI 100 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONH. Lundbeck A/S
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Iceland · Vyepti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/637f6d9a-4cd5-4e57-937b-1e65bb15f567 GET /v1/drugs/637f6d9a-4cd5-4e57-937b-1e65bb15f567?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Eptinezumab",
"merkevare_id": "ID_738AE9FD-BCAE-4DBD-85EB-B21DF1B55C54",
"name_form_strength": "Vyepti kons til inf oppl 100 mg",
"prescription_group": "C"
}See everything about eptinezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.